基础医学论著

miR-17-5p通过颅缝间充质干细胞调节成骨分化*

  • 王润泽 ,
  • 霍银萍 ,
  • 陈奇 ,
  • 邵国 ,
  • 赵志军 ,
  • 张春阳 ,
  • 冯士军
展开
  • 1.内蒙古科技大学包头医学院,内蒙古包头 014040;
    2.内蒙古科技大学包头医学院第一附属医院神经外科;
    3.内蒙古科技大学包头医学院第一附属医院中心实验室;
    4.内蒙古自治区低氧转化医学重点实验室
冯士军

收稿日期: 2025-04-30

  网络出版日期: 2025-10-11

基金资助

*国家自然科学基金(82360188)

miR-17-5p regulates osteogenic differentiation through suture mesenchymal stem cells

  • WANG Runze ,
  • HUO Yinping ,
  • CHEN Qi ,
  • SHAO Guo ,
  • ZHAO Zhijun ,
  • ZHANG Chunyang ,
  • FENG Shijun
Expand
  • 1. Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014040, China;
    2. Department of Neurosurgery, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology;
    3. Central Laboratory, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology;
    4. Key Laboratory of Hypoxia Translation Medicine, Inner Mongolia Autonomous Region

Received date: 2025-04-30

  Online published: 2025-10-11

摘要

目的:探究miR-17-5p对颅缝处颅骨的间充质干细胞(SuSCs)成骨分化的调节作用,并进一步揭示其可能的作用机制。方法:(1)提取并培养SD大鼠SuSCs,使用成骨诱导液诱导后,利用碱性磷酸酶(ALP)染色、茜素红染色、RT-qPCR来鉴定其成骨能力,再利用流式细胞术鉴定所提取SuSCs的纯度。(2)构建miR-17-5p的过表达和干扰载体并转染至SuSCs细胞,利用ALP染色、茜素红染色、RT-qPCR来检测过表达或干扰miR-17-5p对SuSCs成骨分化的影响。(3)过表达或干扰miR-17-5p载体并转染至SuSCs细胞,利用WB检测转染后细胞TGF-β、Smad7的表达。结果:成功提取SuSCs细胞;SuSCs过表达miR-17-5p后ALP染色、茜素红染色、RT-qPCR检测成骨相关标志物(ALP、OCN、Runx2、BMP2)的结果均展现出促进成骨分化的趋势;而SuSCs干扰miR-17-5p后,ALP染色、茜素红染色、RT-qPCR检测成骨相关标志物(ALP、OCN、Runx2、BMP2)的结果均展现出抑制成骨分化的趋势。WB结果显示,相较于空白对照组,过表达miR-17-5p显著提高了TGF-β蛋白的表达水平,同时显著降低了Smad7蛋白的表达水平;而干扰miR-17-5p则展现出相反结果。结论:miR-17-5p参与SuSCs的成骨分化,并通过调节TGF-β/Smad7信号通路发挥关键作用。

本文引用格式

王润泽 , 霍银萍 , 陈奇 , 邵国 , 赵志军 , 张春阳 , 冯士军 . miR-17-5p通过颅缝间充质干细胞调节成骨分化*[J]. 包头医学院学报, 2025 , 41(9) : 25 -32 . DOI: 10.16833/j.cnki.jbmc.2025.09.005

Abstract

Objective: To investigate the regulatory role of miR-17-5p in the osteogenic differentiation of suture mesenchymal stem cells (SuSCs) and further explore its potential mechanism. Methods: (1)SuSCs of the cranial suture in SD rats were extracted and cultured. After induction with osteogenic induction solution, the expression levels of osteogenic markers (ALP, OCN, Runx2, BMP2) were detected by alkaline phosphatase (ALP) staining, alizarin red staining and RT-qPCR, respectively. The osteogenic ability was identified, and the purity of the extracted SuSCs was identified by flow cytometry. (2)The overexpression and interference vectors of miR-17-5p were constructed and transfected into SuSCs cells. The expression levels of osteogenic markers (ALP, OCN, Runx2, BMP2) were detected by alkaline phosphatase (ALP) staining, alizarin red staining and RT-qPCR, respectively. The effects of overexpression or interference of miR-17-5p on osteogenic differentiation of SuSCs were detected. (3)After overexpressing or interfering with miR-17-5p and transfecting SuSCs cells, WB was used to detect the mechanism of its effect on TGF-β and Smad7. Results: SuSCs cells were successfully extracted. The results of ALP staining, alizarin red staining and RT-qPCR detection of osteogenesis-related markers (ALP, OCN, Runx2, BMP2) after overexpression of miR-17-5p in SuSCs showed a trend of promoting osteogenic differentiation. After SuSCs interfered with miR-17-5p, ALP staining, alizarin red staining and RT-qPCR detection of osteogenic markers (ALP, OCN, Runx2, BMP2) showed a trend of inhibiting osteogenic differentiation. WB results showed that compared with the blank control group, overexpression of miR-17-5p significantly increased the expression level of TGF-β protein and significantly decreased the expression level of Smad7 protein, while interfering with miR-17-5p showed the opposite results. Conclusion: miR-17-5p is involved in the osteogenic differentiation of SuSCs and exerts a critical regulatory role by modulating the TGF-β/Smad7 signaling pathway.

参考文献

[1] Li J, von Campe G, Pepe A, et al. Automatic skull defect restoration and cranial implant generation for cranioplasty[J]. Med Image Anal, 2021, 73: 102171.
[2] Xu S, Niu F, Chen Y, et al. Repairing Cranial Defect With Autogenous Mandibular Outer Plate[J]. J Craniofac Surg, 2020, 31(6): 1768-1772.
[3] McCarthy JG, Zide BM. The spectrum of calvarial bone grafting: introduction of the vascularized calvarial bone flap[J]. Plast Reconstr Surg, 1984, 74(1): 10-18.
[4] Teng SW, Lo YS, Liu WT, et al. A genome-wide comparison ofmesenchymal stem cells derived from human placenta and umbilical cord[J]. Taiwan J Obstet Gynecol, 2017, 56(5): 664-671.
[5] Park D, Spencer JA, Koh BI, et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration[J]. Cell Stem Cell, 2012, 10(3): 259-272.
[6] Weilner S, Grillari-Voglauer R, Redl H, et al. The role of microRNAs in cellular senescence and age-related conditions of cartilage and bone[J]. Acta Orthop, 2015, 86(1): 92-99.
[7] Weilner S, Schraml E, Wieser M, et al. Secreted microvesicular miR-31 inhibits osteogenic differentiation of mesenchymal stem cells[J]. Aging Cell, 2016, 15(4): 744-754.
[8] Mohan S, Wergedal JE, Das S, et al. Conditional disruption of miR17-92 cluster in collagen type I-producing osteoblasts results in reduced periosteal bone formation and bone anabolic response to exercise[J]. Physiol Genomics, 2015, 47(2): 33-43.
[9] Jia J, Feng X, Xu W, et al. MiR-17-5p modulates osteoblastic differentiation and cell proliferation by targeting SMAD7 in non-traumatic osteonecrosis[J]. Exp Mol Med, 2014, 46(7): e107.
[10] Liu W, Qi M, Konermann A, et al. The p53/miR-17/Smurf1 pathway mediates skeletal deformities in an age-related model via inhibiting the function of mesenchymal stem cells[J]. Aging (Albany NY), 2015, 7(3): 205-218.
[11] Zhu H, Kavsak P, Abdollah S, et al. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation[J]. Nature, 1999, 400(6745): 687-693.
[12] Yu F, Guo Y, Chen B, et al. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7[J]. Lab Invest, 2015, 95(7): 781-789.
[13] Zou ML, Chen ZH, Teng YY, et al. The Smad Dependent TGF-β and BMP Signaling Pathway in Bone Remodeling and Therapies[J]. Front Mol Biosci, 2021, 8: 593310.
[14] Otsuka M. Foreword. Bioceramic research on intelligent implants and drug delivery system[J]. Biol Pharm Bull, 2013, 36(11): 1653.
[15] 岳莹莹, 靳小雷. 颅缝间充质干细胞在颅缝早闭症中的研究进展[J]. 中华整形外科杂志, 2023, 39(9): 1028-1034
[16] Li W, Zhao J, Wang J, et al. ROCK-TAZ signaling axis regulates mechanical tension-induced osteogenic differentiation of rat cranial sagittal suture mesenchymal stem cells[J]. J Cell Physiol, 2020, 235(9): 5972-5984.
[17] Bai X, Hua S, Zhang J, et al. The MicroRNA Family Both in Normal Development and in Different Diseases: The miR-17-92 Cluster[J]. Biomed Res Int, 2019, 2019: 9450240.
[18] Zheng L, Tu Q, Meng S, et al. Runx2/DICER/miRNA Pathway in RegulatingOsteogenesis[J]. J Cell Physiol, 2017, 232(1): 182-191.
[19] Fang T, Wu Q, Zhou L, et al. miR-106b-5p and miR-17-5p suppress osteogenic differentiation by targeting Smad5 and inhibit bone formation[J]. Exp Cell Res, 2016, 347(1): 74-82.
[20] Li H, Li T, Wang S, et al. miR-17-5p and miR-106a areinvolved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells[J]. Stem Cell Res, 2013, 10(3): 313-324.
[21] Wei B, Wei W, Zhao B, et al. Long non-coding RNA HOTAIR inhibits miR-17-5p to regulate osteogenic differentiation and proliferation in non-traumatic osteonecrosis of femoral head[J]. PLoS One, 2017, 12(2): e0169097.
[22] Humeres C, Shinde AV, Hanna A, et al. Smad7 effects on TGF-β and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure[J]. J Clin Invest, 2022, 132(3):e146926.
文章导航

/